Rajeev Shah's Insider Trades & SAST Disclosures
Rajeev Shah's most recent trade in Black Diamond Therapeutics Inc was a trade of 16,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 16, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rajeev Shah.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics... | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Kala Pharmaceuticals Inc | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Rajeev Shah | Director, Ten Percent Owner | 16 Jun 2021 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) | ||
| Black Diamond Therapeutics... | Rajeev Shah | Director | Other type of transaction at price $ 24.01 per share. | 20 May 2021 | 443 | 0 (0%) | 0% | 24.0 | 10,636 | Common Stock |
| Black Diamond Therapeutics... | Rajeev Shah | Director | Other type of transaction at price $ 24.26 per share. | 01 Apr 2021 | 353,814 | 2,277,978 (6%) | 0% | 24.3 | 8,583,528 | Common Stock |
| Black Diamond Therapeutics... | Rajeev Shah | Director | Grant, award, or other acquisition of securities at price $ 24.01 per share. | 18 Mar 2021 | 443 | 443 (0%) | 0% | 24.0 | 10,636 | Common Stock |
| Solid Biosciences Inc | Rajeev Shah | Director, Ten Percent Owner | 10 Dec 2020 | 4,938,282 | 8,709,882 (18%) | 10% | 3.7 | 18,271,643 | Common Stock | |
| Kala Pharmaceuticals Inc | Rajeev Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Rajeev Shah | Director | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to But) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges